мȸ ǥ ʷ


Warning: getimagesize(/home/virtual/circulationadmin/renewal/econgress/conference/abstract/img_files/PAHsurvival.jpg) [function.getimagesize]: failed to open stream: No such file or directory in /home/virtual/circulationadmin/new/econgress/conference/manage/schedule/view_abstract.php on line 164
ǥ : ȣ - 540638   40 
Pulmonary Arterial Hypertension: A Single Center Experience
가천의대 심장센터 심장내과¹, 가천심혈관연구소², 심장소아과³, 류마티스내과⁴, 호흡기내과5
박예민¹ ², 정욱진¹ ², , 최덕영² ³, 백한주⁴, 정성환5, 신권철¹ ², 강웅철¹ ², 신미승¹ ², 한승환¹ ², 고광곤¹ ², 안태훈¹ ², 최인석¹ ², 신익균¹ ²
Background and Objectives: Pulmonary arterial hypertension (PAH) is an orphan disease showing poor prognosis. The purpose of this study was to characterize PAH by evaluating the etiology, clinical and hemodynamic variables and clinical outcomes in Korean. Methods: A total of thirty nine patients who were diagnosed with PAH at Gachon University Gil Hospital between February 2000 and March 2010 were reviewed retrospectively. The patients with PAH by classification of Dana Point 2008 were included. Results: A total 39 patients, 31 patients (79.5%) were female. The median age at the time of diagnosis was 38.0±15.5 years and the median follow-up period was 47.0±43.3 months. The causes of PAH were congenital heart disease in 21 patients (53.8%), collagen vascular disease associated in 7 patients (17.9%), idiopathic PAH in 5 patients (12.8%), thyroid disorder associated in 3 patients (7.7%) and portal hypertension associated in 2 patients (5.1%) . The most common presenting symptom was dyspnea in 26 patients (66.7%) and 10 patients (25.6%) were NYHA functional classification III or IV at the time of diagnosis. The mean value of right ventricular systolic pressure and mean pulmonary artery pressure (mPAP) by Mahan’s equation on echocardiography were 93.1±32.9 mmHg and 46.6±12.4mmHg, respectively. Seventeen patients (43.6%) underwent right heart catheterization and vasoreactivity test. The mPAP was 56.9±16.8mmHg and 3 patient (7.7%) showed response to vasodilator in vasoreactivity test. Eight patients (20.5%) died during follow-up duration and 1-, 2- and 8 year survival rates were 91.4%, 80.1% and 65.2%, respectively. Median overall survival time of patients NYHA functional classification I or II were significantly longer than patients with III or IV. (p<0.00) (Figure 1.) Conclusion: As reported in other country’s reports, the NYHA functional classification at time of diagnosis was a one of the most powerful predictors of survival. So, the early screening and referral to the expert center is crucial to improve the prognosis.
̹ 󼼺


[ư]


logo 학술대회일정 사전등록안내 초록등록안내 초록등록/관리 숙박 및 교통 안내 전시 및 광고